DNA-supramolecule conjugates in theranostics

Theranostics. 2019 May 18;9(11):3262-3279. doi: 10.7150/thno.31885. eCollection 2019.

Abstract

The elegant properties of deoxyribonucleic acid (DNA), such as accurate recognition, programmability and addressability, make it a well-defined and promising material to develop various molecular probes, drug delivery carriers and theranostic systems for cancer diagnosis and therapy. In addition, supramolecular chemistry, also termed "chemistry beyond the molecule", is a promising research field that aims to develop functional chemical systems by bringing discrete molecular components together in a manner that invokes noncovalent intermolecular forces, such as hydrophobic interaction, hydrogen bonding, metal coordination, and shape or size matching. Thus, DNA-supramolecule conjugates (DSCs) combine accurate recognition, programmability and addressability of DNA with the greater toolbox of supramolecular chemistry. This review discusses the applications of DSCs in sensing, protein activity regulation, cell behavior manipulation, and biomedicine.

Keywords: DNA nanotechnology; DNA-supramolecule conjugate; aptamer; host-guest interaction; supramolecular chemistry.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • DNA / metabolism*
  • Macromolecular Substances / chemistry
  • Macromolecular Substances / metabolism*
  • Multifunctional Nanoparticles / chemistry
  • Multifunctional Nanoparticles / metabolism*
  • Theranostic Nanomedicine / methods*
  • Theranostic Nanomedicine / trends

Substances

  • Macromolecular Substances
  • DNA